Markets › India › BOM › 544759

Goldline Pharmaceutical Ltd

BOM:544759Distribution Services

₹32.00−1.48%At closeAt close · Mon 19 Oct · ≈ AED 1.24 · Market cap $3.28M

Ratio	FY2022	FY2022	FY2023	FY2024	FY2025	YoY
Gross margin	46.4%	46.4%	53.6%	43.8%	45.0%	+1.2 pts
Operating margin	—	11.2%	17.7%	21.0%	21.9%	+0.9 pts
Net margin	1.3%	1.3%	7.7%	10.1%	13.2%	+3.1 pts
EBITDA margin	12.1%	12.1%	18.4%	21.9%	22.7%	+0.8 pts
Return on equity	—	4.4%	23.0%	27.6%	28.9%	+1.3 pts
Return on assets	1.3%	1.3%	7.9%	10.8%	14.3%	+3.4 pts
Return on capital employed	—	21.4%	32.7%	40.9%	40.7%	−0.1 pts
Debt / equity	—	1.8×	1.4×	1.1×	0.6×	−40.2%
Debt / assets	55.9%	55.9%	48.5%	42.1%	31.7%	−10.4 pts
Interest coverage	0.0×	1.4×	2.6×	3.4×	5.2×	+51.9%
Current ratio	—	1.9×	1.9×	2.0×	2.2×	+8.8%
Quick ratio	—	1.3×	1.2×	1.3×	1.6×	+23.0%
Cash ratio	—	0.0×	0.1×	0.1×	0.0×	−53.6%
Asset turnover	1.0×	1.0×	1.0×	1.1×	1.1×	+0.8%
Inventory turnover	—	1.9×	1.5×	2.0×	2.5×	+29.1%
Receivables turnover	—	1.8×	2.1×	2.1×	1.7×	−18.1%
Dividend payout	—	84.5%	12.0%	7.6%	5.3%	−2.3 pts